ARTA
CTSO icon

A.R.T. Advisors’s Cytosorbents Corp CTSO Stock Holding History

A.R.T. Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-26,703
Closed -$216K – 1361
2018
Q4 		$216K Buy
+26,703
New +$265K 0.01% 1030
2018
Q3 		– Sell
-11,647
Closed -$132K – 1450
2018
Q2 		$132K Buy
+11,647
New +$110K 0.01% 1275
2018
Q1 		– Sell
-10,647
Closed -$69K – 1540
2017
Q4 		$69K Buy
+10,647
New +$67.7K ﹤0.01% 1280
2016
Q1 		– Sell
-14,033
Closed -$78K – 1408
2015
Q4 		$78K Buy
+14,033
New +$95.5K ﹤0.01% 1350

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

A.R.T. Advisors's CTSO Position: Q1 2019 in Review

A.R.T. Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2019, closing a stake of 26,703 shares — an estimated $216K sold.

A.R.T. Advisors first reported a position in CTSO in Q4 2015 and held it in 4 quarters. The position peaked at $216K in Q4 2018. 77 funds tracked by Wall St. Rank hold CTSO as of Q1 2019.

  • A.R.T. Advisors reported no remaining Cytosorbents Corp position as of Q1 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 26,703 Cytosorbents Corp shares in Q1 2019, an estimated $216K.
  • A.R.T. Advisors first reported a position in Cytosorbents Corp in Q4 2015 and held it in 4 quarters.
  • A.R.T. Advisors's Cytosorbents Corp position peaked at $216K in Q4 2018.
  • 77 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.